Matches in Wikidata for { <http://www.wikidata.org/entity/Q38392521> ?p ?o ?g. }
- Q38392521 description "2016 nî lūn-bûn" @default.
- Q38392521 description "2016 թվականի մայիսի 10-ին հրատարակված գիտական հոդված" @default.
- Q38392521 description "2016年の論文" @default.
- Q38392521 description "2016年論文" @default.
- Q38392521 description "2016年論文" @default.
- Q38392521 description "2016年論文" @default.
- Q38392521 description "2016年論文" @default.
- Q38392521 description "2016年論文" @default.
- Q38392521 description "2016年论文" @default.
- Q38392521 description "2016年论文" @default.
- Q38392521 description "2016年论文" @default.
- Q38392521 description "2016年论文" @default.
- Q38392521 description "2016年论文" @default.
- Q38392521 description "2016年论文" @default.
- Q38392521 description "2016년 논문" @default.
- Q38392521 description "article científic" @default.
- Q38392521 description "article scientific" @default.
- Q38392521 description "article scientifique" @default.
- Q38392521 description "articol științific" @default.
- Q38392521 description "articolo scientifico" @default.
- Q38392521 description "artigo científico" @default.
- Q38392521 description "artigo científico" @default.
- Q38392521 description "artigo científico" @default.
- Q38392521 description "artikel ilmiah" @default.
- Q38392521 description "artikull shkencor" @default.
- Q38392521 description "artikulong pang-agham" @default.
- Q38392521 description "artykuł naukowy" @default.
- Q38392521 description "artículo científico" @default.
- Q38392521 description "artículu científicu espublizáu en 2016" @default.
- Q38392521 description "bilimsel makale" @default.
- Q38392521 description "bài báo khoa học" @default.
- Q38392521 description "naučni članak" @default.
- Q38392521 description "scienca artikolo" @default.
- Q38392521 description "scientific article published on 10 May 2016" @default.
- Q38392521 description "scientific article published on 10 May 2016" @default.
- Q38392521 description "scientific article published on 10 May 2016" @default.
- Q38392521 description "teaduslik artikkel" @default.
- Q38392521 description "tieteellinen artikkeli" @default.
- Q38392521 description "tudományos cikk" @default.
- Q38392521 description "vedecký článok" @default.
- Q38392521 description "vetenskaplig artikel" @default.
- Q38392521 description "videnskabelig artikel" @default.
- Q38392521 description "vitenskapelig artikkel" @default.
- Q38392521 description "vitskapeleg artikkel" @default.
- Q38392521 description "vědecký článek" @default.
- Q38392521 description "wetenschappelijk artikel" @default.
- Q38392521 description "wissenschaftlicher Artikel" @default.
- Q38392521 description "επιστημονικό άρθρο" @default.
- Q38392521 description "мақолаи илмӣ" @default.
- Q38392521 description "наукова стаття, опублікована в травні 2016" @default.
- Q38392521 description "научна статия" @default.
- Q38392521 description "научная статья" @default.
- Q38392521 description "научни чланак" @default.
- Q38392521 description "научни чланак" @default.
- Q38392521 description "מאמר מדעי" @default.
- Q38392521 description "مقالة علمية نشرت في 10 مايو 2016" @default.
- Q38392521 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38392521 description "บทความทางวิทยาศาสตร์" @default.
- Q38392521 description "სამეცნიერო სტატია" @default.
- Q38392521 name "Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours" @default.
- Q38392521 name "Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours" @default.
- Q38392521 name "Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours" @default.
- Q38392521 type Item @default.
- Q38392521 label "Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours" @default.
- Q38392521 label "Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours" @default.
- Q38392521 label "Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours" @default.
- Q38392521 prefLabel "Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours" @default.
- Q38392521 prefLabel "Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours" @default.
- Q38392521 prefLabel "Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours" @default.
- Q38392521 P1433 Q38392521-9D19710E-A7C2-4B22-9C6D-DDFCFCB384F6 @default.
- Q38392521 P1476 Q38392521-1D9915D6-D199-4378-9B6A-E8FCAC24B25A @default.
- Q38392521 P2093 Q38392521-0582BDEA-8000-4FED-84C6-3DA18A5DF340 @default.
- Q38392521 P2093 Q38392521-5746D860-9564-48B3-9B13-BEE61EF352C1 @default.
- Q38392521 P2093 Q38392521-86F92555-E04F-4336-850F-A5FDDA76828B @default.
- Q38392521 P2093 Q38392521-99DD368A-D01C-43F5-8904-E1F61448739F @default.
- Q38392521 P2093 Q38392521-9EA63AA5-057E-4B76-9262-81606EEE113E @default.
- Q38392521 P2093 Q38392521-B6ECFB45-B978-4A15-9CD7-60EBDDF6F29A @default.
- Q38392521 P2093 Q38392521-D314C5EB-7C43-435D-8AD0-88B837EA0A31 @default.
- Q38392521 P2093 Q38392521-DE86528A-A4A7-48AD-8BED-2E733C1F8036 @default.
- Q38392521 P2093 Q38392521-F8430D57-B07D-451E-8855-51D3C6FF28DF @default.
- Q38392521 P304 Q38392521-0B45EEA0-66BB-4D1D-AC29-67E112CDCFD7 @default.
- Q38392521 P31 Q38392521-64B66539-99E5-48E4-8D1A-1B578B84C73B @default.
- Q38392521 P356 Q38392521-24AB1B09-39B9-44F9-B9A0-498C48B962D3 @default.
- Q38392521 P478 Q38392521-3A5DD2E6-62D0-4635-A85B-BE19FAC4E347 @default.
- Q38392521 P50 Q38392521-249A4C61-F2F5-47B0-BFC1-84D5B8E38983 @default.
- Q38392521 P50 Q38392521-BB21F0A8-C6E1-499F-B730-8715FAF4B601 @default.
- Q38392521 P50 Q38392521-CC1A66BD-BAE7-4EB0-A7FD-4169F68AB631 @default.
- Q38392521 P577 Q38392521-478DDB66-0F97-4AB0-BC5F-52D88D2F8821 @default.
- Q38392521 P698 Q38392521-D9D77133-7033-4C71-84DC-46A43D89D9EC @default.
- Q38392521 P356 J.EJCA.2016.03.084 @default.
- Q38392521 P698 27185573 @default.
- Q38392521 P1433 Q332260 @default.
- Q38392521 P1476 "Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours" @default.
- Q38392521 P2093 "Andrew D J Pearson" @default.
- Q38392521 P2093 "Arne Van Schanke" @default.
- Q38392521 P2093 "Lia Gore" @default.
- Q38392521 P2093 "Margaret E Macy" @default.
- Q38392521 P2093 "Robert Iannone" @default.
- Q38392521 P2093 "Rui Wang" @default.
- Q38392521 P2093 "Ryan Geschwindt" @default.